Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.48% vs 52.17% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 243.32% vs 10.13% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 104.28% vs 10.56% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 300.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Sichuan Goldstone Asia Pharmaceutical, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.48% vs 52.17% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 13.72% vs -19.65% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 243.32% vs 10.13% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 86.31% vs -30.61% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 104.28% vs 10.56% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 26.66% vs -30.86% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 300.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -33.33% vs 50.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






